Five additional patient deaths have been tied to liquid-filled intragastric balloons used to treat obesity, bringing the total to 12 deaths since 2016. US FDA announced June 4 that it has approved updated labeling to update the risks statement.
The revisions include new mortality statistics, as well as more information on how to manage patients experiencing side effects. FDA says the death rate tied to the balloons is 0.06%...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?